Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents

被引：69
|
作者：
Doherty, AM [1 ]
机构：
[1] Inst Rech Jouveinal Parke Davis, F-94265 Fresnes, France
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 1999年 / 3卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(99)80068-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Preclinical and clinical studies of phosphodiesterase 4 inhibitors have shown that these agents may find utility in a wide range of inflammatory disorders, including asthma, chronic obstructive pulmonary disease, atopic dermatitis, rheumatoid arthritis, multiple sclerosis and various neurological disorders. The future of this class of drugs will depend upon the ability to demonstrate a reasonable safety margin against emesis and other typical phosphodieserase (PDE4) side effects, as well as in identification of the inflammatory disorder(s) most relevant to PDE4 inhibition.
引用
收藏
页码：466 / 473
页数：8
相关论文
共 50 条
  • [1] Phosphodiesterase (PDE)4 inhibitors: Anti-inflammatory drugs of the future?
    Teixeira, MM
    Gristwood, RW
    Cooper, N
    Hellewell, PG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (05) : 164 - 170
  • [2] Histone deacetylase inhibitors as novel anti-inflammatory agents
    Adcock, Ian M.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (11) : 966 - 973
  • [3] The role of theophylline and phosphodiesterase 4 isoenzyme inhibitors as anti-inflammatory drugs
    Spina, D
    Landells, LJ
    Page, CP
    CLINICAL AND EXPERIMENTAL ALLERGY, 1998, 28 : 24 - 34
  • [4] Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
    Illig, Carl R.
    Chen, Jinsheng
    Wall, Mark J.
    Wilson, Kenneth J.
    Ballentine, Shelley K.
    Rudolph, M. Jonathan
    DesJarlais, Renee L.
    Chen, Yanmin
    Schubert, Carsten
    Petrounia, Ioanna
    Crysler, Carl S.
    Molloy, Christopher J.
    Chaikin, Margery A.
    Manthey, Carl L.
    Player, Mark R.
    Tomczuk, Bruce E.
    Meegalla, Sanath K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (05) : 1642 - 1648
  • [5] In Silico Identification of Novel Leukotriene A(4) Hydrolase Inhibitors as Potential Anti-Inflammatory Agents
    Al-Balas, Qosay
    Hassan, Mohammad
    Mhaidat, Nizar
    Almaaytah, Ammar
    JORDAN JOURNAL OF CHEMISTRY, 2013, 8 (03) : 199 - 211
  • [6] NOVEL ANTI-INFLAMMATORY AGENTS
    CULLEN, E
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (05) : 579 - 589
  • [7] HDAC inhibitors as anti-inflammatory agents
    Adcock, I. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (07) : 829 - 831
  • [8] CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors
    Alexander, RP
    Warrellow, GJ
    Eaton, MAW
    Boyd, EC
    Head, JC
    Porter, JR
    Brown, JA
    Reuberson, JT
    Hutchinson, B
    Turner, P
    Boyce, B
    Barnes, D
    Mason, B
    Cannell, A
    Taylor, RJ
    Zomaya, A
    Millican, A
    Leonard, J
    Morphy, R
    Wales, M
    Perry, M
    Allen, RA
    Gozzard, N
    Hughes, B
    Higgs, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (11) : 1451 - 1456
  • [9] Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors
    Banner, KH
    Page, CP
    CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 : 2 - 9
  • [10] Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents
    Xu, Yao
    Chen, Shujun
    Cao, Ying
    Zhou, Pingzheng
    Chen, Zhipeng
    Cheng, Kui
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 154 : 253 - 266
12345